AU3580001A - Modulators of the endocannabinoid uptake and of the vallinoid receptors - Google Patents

Modulators of the endocannabinoid uptake and of the vallinoid receptors

Info

Publication number
AU3580001A
AU3580001A AU35800/01A AU3580001A AU3580001A AU 3580001 A AU3580001 A AU 3580001A AU 35800/01 A AU35800/01 A AU 35800/01A AU 3580001 A AU3580001 A AU 3580001A AU 3580001 A AU3580001 A AU 3580001A
Authority
AU
Australia
Prior art keywords
vallinoid
endocannabinoid
modulators
uptake
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35800/01A
Inventor
David Baker
Tiziana Bisogno
Luciano De Petrocellis
Vincenzo Di Marzo
Gareth Pryce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0004895A external-priority patent/GB0004895D0/en
Priority claimed from GB0027989A external-priority patent/GB0027989D0/en
Application filed by University College London filed Critical University College London
Publication of AU3580001A publication Critical patent/AU3580001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35800/01A 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors Abandoned AU3580001A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0004895 2000-03-01
GB0004895A GB0004895D0 (en) 2000-03-01 2000-03-01 Inhibitor
GB0027989 2000-11-16
GB0027989A GB0027989D0 (en) 2000-11-16 2000-11-16 Modulator
PCT/GB2001/000858 WO2001064212A1 (en) 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors

Publications (1)

Publication Number Publication Date
AU3580001A true AU3580001A (en) 2001-09-12

Family

ID=26243768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35800/01A Abandoned AU3580001A (en) 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors

Country Status (2)

Country Link
AU (1) AU3580001A (en)
WO (1) WO2001064212A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CN101787073B (en) 2003-01-28 2013-12-25 艾恩伍德医药品股份有限公司 Methods and compositions for treatment of gastrointestinal disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ES2657938T3 (en) 2008-12-31 2018-03-07 Ardelyx, Inc. Compounds and methods to inhibit NHE-mediated anti-port in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN104902930A (en) 2012-08-21 2015-09-09 阿德利克斯公司 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
ES2735992T3 (en) 2013-04-12 2019-12-23 Ardelyx Inc NHE3 binding compounds and procedures to inhibit phosphate transport
RS65632B1 (en) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-pure agonists of guanylate cyclase c, method of making and using same
EP3565808A1 (en) 2017-01-09 2019-11-13 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
EA201991676A1 (en) 2017-01-09 2020-01-30 Арделикс, Инк. NHE-MEDIATED ANTI-PORT INHIBITORS
TW202325306A (en) 2021-09-02 2023-07-01 美商天恩治療有限公司 Methods of improving growth and function of immune cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
CA2337822A1 (en) * 1998-06-09 1999-12-16 The University Of Connecticut Inhibitors of the anandamide transporter as analgesic agents
HN1998000027A (en) * 1998-08-19 1999-06-02 Bayer Ip Gmbh Arylsulphonamides and analogues
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
WO2001064212A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU3580001A (en) Modulators of the endocannabinoid uptake and of the vallinoid receptors
AU2002347328A1 (en) Fixing device and applicator therefor
AU2002338914A1 (en) Cosmetic agents
AU2002336234A1 (en) Dynamic mixer
AU2001229667A1 (en) Automatically modulating acupressure device
AU2001252135A1 (en) Therapeutic agents
AUPQ676800A0 (en) Dental device
AU2002224823A1 (en) Rubber compounds that contain gels and inorganic peroxides
AU2001273423A1 (en) Liquid applicator
AU2001292185A1 (en) Formulation containing amoxicillin
AU2001291072A1 (en) Releasable strap
AU2001286061A1 (en) Applicator
AU2001272974A1 (en) Human receptors
AU2002239454A1 (en) Ace-2 modulating compounds and use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001235363A1 (en) Mibefradil analogues and their use
AU2001274523A1 (en) Liquid applicator
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001273903A1 (en) Therapeutic agents
AU2001252627A1 (en) Polybenzasol fiber and use of the same
AU2001253461A1 (en) Coated anchoring device
AU2001267584A1 (en) Dynamic mixer
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001275696A1 (en) Therapeutic agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase